Skip to main content

Table 5 Demographic characteristics of the INTERVAL cohort by recruitment sourcea

From: Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals

Demographics

INTERVAL cohort

n (%) or mean (SD)

Centre

Mobile (platelet)

Mobile (10-mile)

Mobile (30-mile)

No invitation

All donors

31,929 (100.0 %)

1741 (100.0 %)

5237 (100.0 %)

2409 (100.0 %)

7376 (100.0 %)

Sex

 Male

15,996 (50.1 %)

1379 (79.2 %)

2196 (41.9 %)

1110 (46.1 %)

3531 (47.9 %)

 Female

15,933 (49.9 %)

362 (20.8 %)

3041 (58.1 %)

1299 (53.9 %)

3845 (52.1 %)

Age at baseline (years)

43.7 (14.4)

51.2 (13.2)

41.9 (11.7)

45.2 (13.6)

38.3 (14.2)

Age at baseline

 17–24

3866 (12.1 %)

82 (4.7 %)

544 (10.4 %)

268 (11.1 %)

1664 (22.6 %)

 25–34

6688 (20.9 %)

166 (9.5 %)

1102 (21.0 %)

365 (15.2 %)

1915 (26.0 %)

 35–44

5849 (18.3 %)

263 (15.1 %)

1205 (23.0 %)

430 (17.8 %)

1348 (18.3 %)

 45–54

7233 (22.7 %)

446 (25.6 %)

1576 (30.1 %)

612 (25.4 %)

1291 (17.5 %)

 55–64

5938 (18.6 %)

495 (28.4 %)

797 (15.2 %)

734 (30.5 %)

858 (11.6 %)

 65+

2355 (7.4 %)

289 (16.6 %)

13 (0.2 %)

0 (0.0 %)

300 (4.1 %)

Ethnicity

 White

28,924 (90.6 %)

1644 (94.4 %)

4774 (91.2 %)

2227 (92.4 %)

6623 (89.8 %)

 Asian

790 (2.5 %)

12 (0.7 %)

83 (1.6 %)

36 (1.5 %)

206 (2.8 %)

 Black African

78 (0.2 %)

1 (0.1 %)

13 (0.2 %)

2 (0.1 %)

24 (0.3 %)

 Black Caribbean

201 (0.6 %)

5 (0.3 %)

38 (0.7 %)

21 (0.9 %)

42 (0.6 %)

 Black other

24 (0.1 %)

0 (0.0 %)

2 (0.0 %)

3 (0.1 %)

2 (0.0 %)

 Chinese

120 (0.4 %)

1 (0.1 %)

12 (0.2 %)

4 (0.2 %)

27 (0.4 %)

 Mixed

451 (1.4 %)

11 (0.6 %)

67 (1.3 %)

33 (1.4 %)

117 (1.6 %)

 Other

94 (0.3 %)

2 (0.1 %)

14 (0.3 %)

4 (0.2 %)

24 (0.3 %)

 Unknown

1247 (3.9 %)

65 (3.7 %)

234 (4.5 %)

79 (3.3 %)

311 (4.2 %)

Blood group

 A RhD positive (A+)

9414 (29.5 %)

635 (36.5 %)

1612 (30.8 %)

854 (35.5 %)

2222 (30.1 %)

 A RhD negative (A-)

2405 (7.5 %)

209 (12.0 %)

371 (7.1 %)

207 (8.6 %)

552 (7.5 %)

 B RhD positive (B+)

2783 (8.7 %)

121 (7.0 %)

436 (8.3 %)

258 (10.7 %)

646 (8.8 %)

 B RhD negative (B-)

737 (2.3 %)

45 (2.6 %)

96 (1.8 %)

0 (0.0 %)

192 (2.6 %)

 O RhD positive (O+)

11,589 (36.3 %)

485 (27.9 %)

1995 (38.1 %)

1073 (44.5 %)

2500 (33.9 %)

 O RhD negative (O-)

3859 (12.1 %)

199 (11.4 %)

515 (9.8 %)

0 (0.0 %)

969 (13.1 %)

 AB RhD positive (AB+)

880 (2.8 %)

40 (2.3 %)

164 (3.1 %)

0 (0.0 %)

209 (2.8 %)

 AB RhD negative (AB-)

256 (0.8 %)

7 (0.4 %)

48 (0.9 %)

17 (0.7 %)

74 (1.0 %)

 Unknown

6 (0.0 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

12 (0.2 %)

Distance to nearest static donor centre (miles)

 0–4

21,298 (66.7 %)

570 (32.7 %)

3446 (65.8 %)

508 (21.1 %)

4583 (62.1 %)

 5–9

5778 (18.1 %)

471 (27.1 %)

1329 (25.4 %)

818 (34.0 %)

1405 (19.0 %)

 10–29

3946 (12.4 %)

649 (37.3 %)

377 (7.2 %)

1057 (43.9 %)

1174 (15.9 %)

 30–59

538 (1.7 %)

36 (2.1 %)

37 (0.7 %)

13 (0.5 %)

151 (2.0 %)

 60+

68 (0.2 %)

2 (0.1 %)

7 (0.1 %)

7 (0.3 %)

14 (0.2 %)

 Unknown

301 (0.9 %)

13 (0.7 %)

41 (0.8 %)

6 (0.2 %)

49 (0.7 %)

Donor status at baseline

 New

453 (1.4 %)

0 (0.0 %)

6 (0.1 %)

8 (0.3 %)

925 (12.5 %)

 Occasional

4180 (13.1 %)

35 (2.0 %)

1039 (19.8 %)

411 (17.1 %)

2247 (30.5 %)

 More frequent

27,296 (85.5 %)

1706 (98.0 %)

4192 (80.0 %)

1990 (82.6 %)

4204 (57.0 %)

Donations (during the 2 years prior to baseline)

 All donations

3.47 (1.87)

4.28 (1.68)

3.06 (1.66)

3.35 (1.75)

2.39 (2.54)

 Whole-blood donations

3.38 (1.73)

4.13 (1.51)

3.05 (1.65)

3.33 (1.73)

2.15 (1.92)

 Other donations

0.08 (0.89)

0.15 (1.08)

0.01 (0.29)

0.02 (0.32)

0.23 (1.87)

Deferrals (during the 2 years prior to baseline)

 Deferral for low haemoglobin

2597 (8.1 %)

73 (4.2 %)

242 (4.6 %)

119 (4.9 %)

277 (3.8 %)

 Any other deferral

10,174 (31.9 %)

461 (26.5 %)

1238 (23.6 %)

660 (27.4 %)

2095 (28.4 %)

Length of NHSBT donation history at baseline (years)

11.2 (8.4)

14.2 (8.4)

10.2 (8.1)

11.4 (9.1)

7.78 (7.71)

  1. aFor definitions see footnotes to Table 3